
Professor Klaus Parhofer
Disclosure details
Klaus G Parhofer has received research funding and/or honoraria for consultancy and/or speaker’s bureau and/or DMC activity from Akcea, Amarin, Amgen, Berlin-Chemie, Biomarin, Boehringer-Ingelheim, Dr. Schär, Daiichi-Sankyo, MSD, Novartis, Regeneron, Sanofi, and Silence Therapeutics.Professor of Metabolism and Endocrinology at the Medical Department of the Ludwig Maximilians University, Munich, Germany